Literature DB >> 8486776

Low expression allele alpha LELY of red cell spectrin is associated with mutations in exon 40 (alpha V/41 polymorphism) and intron 45 and with partial skipping of exon 46.

R Wilmotte1, J Maréchal, L Morlé, F Baklouti, N Philippe, R Kastally, L Kotula, J Delaunay, N Alloisio.   

Abstract

The alpha V/41 polymorphism of erythroid alpha-spectrin has been characterized initially by an increased susceptibility to proteolysis of the alpha IV-alpha V domain junction (Alloisio N., L. Morlé, J. Maréchal, A.-F. Roux, M.-T. Ducluzeau, D. Guetarni, B. Pothier, F. Baklouti, A. Ghanem, R. Kastally, et al. 1991. J. Clin. Invest. 87:2169-2177). Until now, it has been found associated invariably with a low expression level of the corresponding alpha chain. Among 61 chromosomes investigated in French and North African individuals or kindreds, we observed 19 chromosomes with the alpha V/41 polymorphism. With no single exception, the latter displayed a point mutation in exon 40 (Leu-->Val; CTA-->GTA) at position alpha 1857. According to the triple helical model of spectrin structure, this change accounts for the peptide maps' abnormalities. Sequencing the entire alpha V domain cDNA disclosed, in addition, a partial skipping of exon 46. At the gene level, a substitution (C-->T) was evidenced at nucleotide -12 of intron 45. This mutation appeared linked to the exon 40 mutation in 17 chromosomes, again with no single exception, among 53 examined chromosomes. We hypothesized that the lack of exon 46 would hamper the nucleation process and eventually account for the low expression feature. The present doubly mutated allele was renamed allele alpha LELY (low expression, Lyon).

Mesh:

Substances:

Year:  1993        PMID: 8486776      PMCID: PMC288208          DOI: 10.1172/JCI116432

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Spectrin Jendouba: an alpha II/31 spectrin variant that is associated with elliptocytosis and carries a mutation distant from the dimer self-association site.

Authors:  N Alloisio; R Wilmotte; L Morlé; F Baklouti; J Maréchal; M T Ducluzeau; L Denoroy; C Féo; B G Forget; R Kastally
Journal:  Blood       Date:  1992-08-01       Impact factor: 22.113

Review 2.  Splicing of messenger RNA precursors.

Authors:  R A Padgett; P J Grabowski; M M Konarska; S Seiler; P A Sharp
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

Review 3.  From genes to structural morphogenesis: the genesis and epigenesis of a red blood cell.

Authors:  E Lazarides
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

4.  A structural model of human erythrocyte spectrin. Alignment of chemical and functional domains.

Authors:  D W Speicher; J S Morrow; W J Knowles; V T Marchesi
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

5.  Erythrocyte spectrin is comprised of many homologous triple helical segments.

Authors:  D W Speicher; V T Marchesi
Journal:  Nature       Date:  1984 Sep 13-19       Impact factor: 49.962

6.  Molecular basis of Sp alpha I/65 hereditary elliptocytosis in North Africa: insertion of a TTG triplet between codons 147 and 149 in the alpha-spectrin gene from five unrelated families.

Authors:  A F Roux; F Morlé; D Guetarni; P Colonna; K Sahr; B G Forget; J Delaunay; J Godet
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

7.  Spectrin Oran (alpha II/21), a new spectrin variant concerning the alpha II domain and causing severe elliptocytosis in the homozygous state.

Authors:  N Alloisio; L Morlé; B Pothier; A F Roux; J Maréchal; M T Ducluzeau; Z Benhadji-Zouaoui; J Delaunay
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

8.  Sp alpha I/65 hereditary elliptocytosis in North Africa.

Authors:  N Alloisio; D Guetarni; L Morlé; B Pothier; M T Ducluzeau; A Soun; P Colonna; M Clerc; N Philippe; J Delaunay
Journal:  Am J Hematol       Date:  1986-10       Impact factor: 10.047

9.  Sequence and exon-intron organization of the DNA encoding the alpha I domain of human spectrin. Application to the study of mutations causing hereditary elliptocytosis.

Authors:  K E Sahr; T Tobe; A Scarpa; K Laughinghouse; S L Marchesi; P Agre; A J Linnenbach; V T Marchesi; B G Forget
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

10.  Synthesis and assembly of membrane skeletal proteins in mammalian red cell precursors.

Authors:  M Hanspal; J Palek
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

View more
  18 in total

1.  A novel splicing mutation of the alpha-spectrin gene in the original hereditary pyropoikilocytosis kindred.

Authors:  Daniel B Costa; Larisa Lozovatsky; Patrick G Gallagher; Bernard G Forget
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele.

Authors:  T L McGee; M Devoto; J Ott; E L Berson; T P Dryja
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

3.  Spectrin self-association site: characterization and study of beta-spectrin mutations associated with hereditary elliptocytosis.

Authors:  G Nicolas; S Pedroni; C Fournier; H Gautero; C Craescu; D Dhermy; M C Lecomte
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

4.  Novel exon 2 α spectrin mutation and intragenic crossover: three morphological phenotypes associated with four distinct α spectrin defects.

Authors:  Sabina Swierczek; Archana M Agarwal; Kubendran Naidoo; Felipe R Lorenzo; Jonathan Whisenant; Roberto H Nussenzveig; Neeraj Agarwal; Theresa L Coetzer; Josef T Prchal
Journal:  Haematologica       Date:  2013-09-27       Impact factor: 9.941

Review 5.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

6.  A molecular basis for variation in clinical severity of isolated growth hormone deficiency type II.

Authors:  Rizwan Hamid; John A Phillips; Cindy Holladay; Joy D Cogan; Eric D Austin; Philippe F Backeljauw; Sharon H Travers; James G Patton
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

7.  Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias.

Authors:  Laurent Gouya; Hervé Puy; Anne-Marie Robreau; Said Lyoumi; Jérome Lamoril; Vasco Da Silva; Bernard Grandchamp; Jean-Charles Deybach
Journal:  Hum Genet       Date:  2003-12-11       Impact factor: 4.132

8.  Mapping the locus for familial hypertrophic cardiomyopathy to chromosome 11 in a family with a case of apical hypertrophic cardiomyopathy of the Japanese type.

Authors:  Y L Ko; J J Chen; T K Tang; M S Teng; S Y Lin; P Kuan; C W Wu; W P Lien; C C Liew
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

9.  Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site.

Authors:  Massimiliano Gaetani; Sara Mootien; Sandra Harper; Patrick G Gallagher; David W Speicher
Journal:  Blood       Date:  2008-01-24       Impact factor: 22.113

10.  Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele.

Authors:  L Gouya; J C Deybach; J Lamoril; V Da Silva; C Beaumont; B Grandchamp; Y Nordmann
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.